Wesbanco Bank Inc. Purchases 6,000 Shares of LeMaitre Vascular, Inc. $LMAT

Wesbanco Bank Inc. lifted its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 52.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,400 shares of the medical instruments supplier’s stock after acquiring an additional 6,000 shares during the quarter. Wesbanco Bank Inc.’s holdings in LeMaitre Vascular were worth $1,523,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of LMAT. Advisors Asset Management Inc. raised its position in LeMaitre Vascular by 3.0% in the second quarter. Advisors Asset Management Inc. now owns 4,111 shares of the medical instruments supplier’s stock valued at $341,000 after purchasing an additional 118 shares during the last quarter. Johnson Investment Counsel Inc. grew its holdings in shares of LeMaitre Vascular by 0.5% during the third quarter. Johnson Investment Counsel Inc. now owns 29,792 shares of the medical instruments supplier’s stock worth $2,607,000 after purchasing an additional 153 shares during the last quarter. Federated Hermes Inc. increased its stake in shares of LeMaitre Vascular by 0.4% in the second quarter. Federated Hermes Inc. now owns 39,659 shares of the medical instruments supplier’s stock valued at $3,294,000 after buying an additional 155 shares during the period. Jones Financial Companies Lllp raised its holdings in LeMaitre Vascular by 2.2% in the 3rd quarter. Jones Financial Companies Lllp now owns 7,486 shares of the medical instruments supplier’s stock valued at $630,000 after buying an additional 158 shares during the last quarter. Finally, Illumine Investment Management LLC boosted its position in LeMaitre Vascular by 1.4% during the 3rd quarter. Illumine Investment Management LLC now owns 14,032 shares of the medical instruments supplier’s stock worth $1,228,000 after buying an additional 195 shares during the period. Institutional investors and hedge funds own 84.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on LMAT shares. Roth Mkm restated a “buy” rating and issued a $108.00 price target on shares of LeMaitre Vascular in a research report on Wednesday, November 5th. Wells Fargo & Company reduced their price objective on shares of LeMaitre Vascular from $97.00 to $93.00 and set an “equal weight” rating on the stock in a research note on Friday, November 7th. Zacks Research downgraded LeMaitre Vascular from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 1st. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of LeMaitre Vascular in a report on Monday, December 29th. Finally, Barrington Research reiterated an “outperform” rating and issued a $95.00 price target on shares of LeMaitre Vascular in a research report on Wednesday, October 15th. Four equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, LeMaitre Vascular presently has a consensus rating of “Moderate Buy” and a consensus target price of $100.20.

LeMaitre Vascular Price Performance

Shares of NASDAQ LMAT opened at $87.68 on Wednesday. The company has a market capitalization of $1.99 billion, a PE ratio of 37.79, a P/E/G ratio of 1.92 and a beta of 0.72. The company has a quick ratio of 11.45, a current ratio of 13.58 and a debt-to-equity ratio of 0.44. LeMaitre Vascular, Inc. has a twelve month low of $71.42 and a twelve month high of $105.55. The firm has a fifty day simple moving average of $84.69 and a 200 day simple moving average of $87.83.

About LeMaitre Vascular

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.